Could federated data analysis be the catalyst accelerating the introduction of newborn genome screening for the detection of genetic disease?

Abstract

Data federation intermediated through trusted research environments can help accelerate the adoption and utilization of newborn genome screening worldwide. Data federation will protect individual datasets from unauthorized security breaches, allow analysis in situ, and bypass the need for cumbersome data sharing agreements between parties. Finally, data federation could accelerate the adoption of new therapies for rare genetic diseases with the use of synthetic clinical trials.

Keywords

Newborn genome screening / data federation / trusted research environment

References

[1] Hageman IC,de Blaauw I,King SK.A systematic overview of rare disease patient registries: challenges in design, quality management, and maintenance.Orphanet J Rare Dis2023;18:106 PMCID:PMC10163740

[2] Pogue RE,Shanker S.Rare genetic diseases: update on diagnosis, treatment and online resources.Drug Discov Today2018;23:187-95.

[3] Guthrie R.Blood screening for phenylketonuria.JAMA1961;178:863.

[4] Fidan Ç,Alper AB.Expanded newborn bloodspot screening: developed country examples and what can be done in Turkey.Intractable Rare Dis Res2022;11:63-9 PMCID:PMC9161126

[5] Bick D,Deen D.Newborn screening by genomic sequencing: opportunities and challenges.Int J Neonatal Screen2022;8:40 PMCID:PMC9326745

[6] Ceyhan-Birsoy O,Lebo MS.A curated gene list for reporting results of newborn genomic sequencing.Genet Med2017;19:809-18 PMCID:PMC5507765

[7] Kingsmore SF,Kunard CM.A genome sequencing system for universal newborn screening, diagnosis, and precision medicine for severe genetic diseases.Am J Hum Genet2022;109:1605-19

[8] Kingsmore SF; BeginNGS Consortium. Dispatches from biotech beginning BeginNGS: rapid newborn genome sequencing to end the diagnostic and therapeutic odyssey.Am J Med Genet C Semin Med Genet2022;190:243-56

[9] Gaff CL,M Forrest S.Preparing for genomic medicine: a real world demonstration of health system change.NPJ Genom Med2017;2:16. PMCID:PMC5677913

[10] Holm IA,Ceyhan-Birsoy O.BabySeq Project TeamThe BabySeq project: implementing genomic sequencing in newborns.BMC Pediatr2018;18:225. PMCID:PMC6038274

[11] Pichini A,Patch C.Developing a national newborn genomes program: an approach driven by ethics, engagement and co-design.Front Genet2022;13:866168 PMCID:PMC9195613

[12] Alvarellos M,Knarston I.Democratizing clinical-genomic data: how federated platforms can promote benefits sharing in genomics.Front Genet2022;13:1045450 PMCID:PMC9871385

[13] Chaterji S,Li N,Grama A.Federation in genomics pipelines: techniques and challenges.Brief Bioinform2019;20:235-44 PMCID:PMC6357554

[14] Rehm HL,Smith L.GA4GH: international policies and standards for data sharing across genomic research and healthcare.Cell Genom2021;1:100029. PMCID:PMC8774288

[15] Papez V,Voss EA.Transforming and evaluating the UK Biobank to the OMOP Common Data Model for COVID-19 research and beyond.J Am Med Inform Assoc2022;30:103-11 PMCID:PMC9619789

[16] Mayo KR,Carroll RJ.The all of Us data and research center: creating a secure, scalable, and sustainable ecosystem for biomedical research.Annu Rev Biomed Data Sci2023;6:443-64

[17] Nik-Zainal S,Fennessy R.Multi-party trusted research environment federation: Establishing infrastructure for secure analysis across different clinical-genomic datasets.Zenodo2022:online ahead of print

[18] Rueda M,Moldes M.Beacon v2 reference implementation: a toolkit to enable federated sharing of genomic and phenotypic data.Bioinformatics2022;38:4656-7

[19] Hunter A,Hill M.Public and patient involvement in research to support genome services development in the UK.J Transl Genet Genom2023;7:17-26.

[20] Goldenberg AJ,Brosco JP.Bioethics and Legal Workgroup of the Newborn Screening Translational Research NetworkIncluding ELSI research questions in newborn screening pilot studies.Genet Med2019;21:525-33.

[21] Richards S,Bale S.ACMG Laboratory Quality Assurance CommitteeStandards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.Genet Med2015;17:405-24 PMCID:PMC4544753